Headache

Neurological disease burden in Europe: A new analysis calling for action

2560 1709 Anna Stelling, PhD

The Global Burden of Diseases (GBD) Study 2015 has drawn attention to the substantial and increasing health burden of neurological diseases worldwide.1 In order to adjust public health and disease…

read more

“Less is more” in medication-overuse headache

6668 2484 Peter Stevenson, PhD

Monitoring, recognition and effective patient education are cornerstones in the diagnosis and prevention of medication-overuse headache (MOH), delegates heard at the 5th Annual Congress of the European Academy of Neurology…

read more

3 minutes with Prof. Goadsby – Interview from SNG

150 150 Rachel Park, MA

Professor Peter Sandor interviewed Professor Peter Goadsby at the SNG Annual Meeting this week in Montreux, Switzerland. They spoke about one of the top leading causes of disability–migraine. Watch the…

read more

Quarterly migraine injection approved in US

2885 1900 Peter Stevenson, PhD

The US FDA has approved a new humanised monoclonal antibody for migraine prevention in adults. Fremanezumab-vfrm – under the brand name AJOVYTM (Teva Pharmaceuticals) – prevents the interaction between calcitonin…

read more
Brainwork-Webinar-Video-01-Peter-Goadsby

Trends in Headache Medicine

1920 1080 Rachel Park, MA
Brainwork is supported by unrestricted grants from: